ANRO short interest
Alto Neuroscience Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 4,660,269 |
|---|---|
| Change vs prior report | 486,187 (+11.7%) |
| Change over six months | +127.1% |
| Days to cover | 6.49 (sector: 3.78) |
| Average daily volume | 718,187 |
| Rank in Healthcare | #279 of 922 by days to cover |
ANRO short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 4,660,269 | +11.7% | 6.49 | 718,187 |
| 2026-09-15 | 4,174,082 | +8.8% | 9.08 | 459,493 |
| 2026-08-31 | 3,836,359 | +7.9% | 8.06 | 475,830 |
| 2026-08-14 | 3,556,066 | +9.9% | 7.47 | 475,999 |
| 2026-07-31 | 3,235,210 | +4.5% | 7.45 | 434,265 |
| 2026-07-15 | 3,096,805 | +28.5% | 4.30 | 719,885 |
| 2026-06-30 | 2,410,038 | +48.6% | 2.99 | 805,527 |
| 2026-06-15 | 1,622,197 | -4.1% | 4.34 | 373,591 |
| 2026-05-29 | 1,692,318 | +5.0% | 5.53 | 305,825 |
| 2026-05-15 | 1,611,876 | +1.6% | 4.69 | 343,534 |
| 2026-04-30 | 1,587,188 | -27.6% | 6.06 | 261,988 |
| 2026-04-15 | 2,190,772 | +6.8% | 5.37 | 407,748 |
| 2026-03-31 | 2,051,993 | +3.4% | 5.55 | 370,037 |
| 2026-03-13 | 1,984,788 | -2.9% | 7.96 | 249,337 |
| 2026-02-27 | 2,043,099 | -4.3% | 10.43 | 195,796 |
| 2026-02-13 | 2,135,475 | -0.0% | 8.34 | 256,031 |
| 2026-01-30 | 2,135,587 | -1.6% | 12.76 | 167,344 |
| 2026-01-15 | 2,171,494 | -1.2% | 10.57 | 205,408 |
| 2025-12-31 | 2,198,907 | -20.9% | 4.48 | 490,970 |
| 2025-12-15 | 2,781,726 | +0.5% | 7.84 | 355,034 |
| 2025-11-28 | 2,767,123 | -1.6% | 7.90 | 350,116 |
| 2025-11-14 | 2,810,725 | -1.3% | 6.00 | 468,648 |
| 2025-10-31 | 2,847,368 | +26.6% | 1.35 | 2,113,498 |
| 2025-10-15 | 2,248,165 | +36.9% | 1.00 | 6,084,518 |
| 2025-09-30 | 1,641,893 | +0.0% | 18.16 | 90,405 |
import finzdata as yf
yf.Ticker("ANRO").short_interest # every report since 2017
yf.Client().short_interest(["ANRO"], start="2018-01-01")Healthcare short interest · ANRO price history · Who owns ANRO · All short interest